touchPODCAST

touchCASES for touchNEUROLOGY Listen to two US-based experts as they discuss how to improve diagnostic accuracy in the USA for patients with chronic inflammatory demyelinating polyneuropathy (CIDP). They will discuss three patient cases to illustrate how to recognize and differentiate CIDP variants from other polyneuropathies, and apply key diagnostic criteria to help strengthen a diagnosis. The experts: Dr Karissa Gable, Duke University, Durham, NC, USA Dr Jeffrey Allen, University of Minnesota, Minneapolis, MN, USA This activity is funded by an independent medical education grant from Sanofi Genzyme. This activity is jointly provided by USF Health and touchIME. This activity is for HCPs in the USA only. For further information, visit our website: https://touchneurologyime.org/cidp-diagnostics/  

touchEXPERT FOCUS for touchOPHTHALMOLOGY Listen to a series of interviews with Dr. Diana Do as she shares her expert insights into the epidemiology and quality‑of‑life burden of diabetic macular edema (DME) in the USA, outlines real‑world limitations of current anti‑VEGF–based management, and examines emerging therapies that specifically target blood–retinal barrier (BRB) dysfunction and aim to provide more durable vision protection. The expert: Dr. Diana Do, Stanford University School of Medicine, Palo Alto, CA, USA This touchPODCAST is for HCPs in the USA only. This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC. This activity is jointly provided by USF Health and touchIME. For further information visit our website: www.touchOPHTHALMOLOGY.com   

touchTALKS for touchONCOLOGY Listen to Dr Teresa Alonso-Gordoa, as she evaluates the latest data on dual EZH2/AR inhibition in mCRPC and explores how emerging evidence could influence clinical decision-making in the future. The expert Dr. Teresa Alonso-Gordoa - Hospital Universitario Ramón y Cajal, Madrid, Spain This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Pfizer. This activity is provided by touchIME. touchIME is an EBAC® accredited provider.  For further information visit our website: www.touchONCOLOGY.com

touchEXPERT FOCUS for touchOPHTHALMOLOGY Listen to a series of short interviews with three leading experts discussing neural-targeted therapies for dry eye disease (DED). The faculty describe the neuronal control of tear secretion, explore the mechanisms of action and clinical findings with neuromodulatory/neurostimulatory therapies for DED, and discuss how to integrate these therapies into personalized treatment plans. The experts: Dr Anat Galor – Bascom Palmer Eye Institute, Miami, USA Dr Christopher Starr – Weill Cornell Medicine and NewYork-Presbyterian Hospital, New York, USA Dr Marjan Farid – University of California Irvine Medical Center, Irvine, USA This touchPODCAST is for healthcare professionals in the USA, Canada and Latin America This activity is funded by an independent medical education grant from Alcon Vision LLC. This activity is jointly provided by USF Health and touchIME. For further information visit our website: touchophthalmologyime.org

touchEXPERT FOCUS for touchONCOLOGY and touchRESPIRATORY   Listen to a series of short interviews with leading experts on computational pathology in NSCLC. The faculty, an oncologist, an oncologist-researcher and a pathologist, discuss the clinical value of computational pathology in NSCLC, review emerging tools and share practical insights on how these approaches can be applied in routine patient management. The experts: Prof. Marina Garassino, University of Chicago, IL, USA Prof. Jakob Nikolas Kather, Technical University, Dresden and University Hospital Dresden, Germany Prof. Fernando Lopez-Rios, Hospital Universitario 12 de Octubre, Madrid, Spain This touchPODCAST is for HCPs outside of the UK. This activity is funded by an independent medical education grant from AstraZeneca. The activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our websites: touchONCOLOGY: https://touchoncologyime.org/computational-pathology-in-nsclc-from-biomarker-discovery-to-clinical-integration/ touchRESPIRATORY: https://touchrespiratoryime.org/computational-pathology-in-nsclc-from-biomarker-discovery-to-clinical-integration/

touchPANEL DISCUSSION for touchONCOLOGY Listen to a panel of leading experts discuss the future of care for patients with pancreatic ductal adenocarcinoma, or PDAC.  The faculty provide their insights on the current unmet needs, the evolving role of imaging, biomarker testing, and treatment strategies, and how these developments may impact clinical care. The experts: Dr Eileen O'Reilly - Memorial Sloan Kettering Cancer Center, New York NY, United States Prof. Michel Ducreux - Gustave Roussy Cancer Center, Villejuif, France Dr Thomas Hope - University of California, San Francisco, CA, USA This touchPODCAST is for HCPs outside of the UK. This activity is funded by an independent medical education grant from Advanced Accelerator Applications International S.A. The activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: www.touchONCOLOGY.com 

touchEXPERT FOCUS for touchOPHTHALMOLOGY   Listen to a series of interviews with Dr Maria-João Menéres who will provide her expert insights into the mechanisms of retinal ganglion cell (RGC) damage in both primary open-angle and secondary, steroid-induced glaucoma, and the importance of neuroprotection to mitigate the risk of glaucoma development or progression. The expert: Dr Maria-João Menéres, ULS Santo António, Porto, Portugal This touchPODCAST is for HCPs in Portugal only. This activity is funded by an independent medical education grant from Alimera Sciences Europe Limited. The activity is provided by touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: www.touchOPHTHALMOLOGY.com   

touchEXPERT FOCUS for touchOPHTHALMOLOGY Listen as Prof. Sumit (Sam) Garg shares expert clinical insights on how AI-supported biometric analysis can increase refractive accuracy and support confident presbyopia-correcting IOL selection, including which patient and ocular characteristics are most likely to benefit from AI-based tools. He also outlines practical strategies for structuring preoperative counselling to set realistic expectations and improve patient satisfaction through clear, effective communication.   The expert: Prof. Sumit (Sam) Garg, University of California, Irvine, CA, USA This touchPODCAST is for HCPs outside of the UK. This educational activity is funded by an independent medical education grant from Johnson & Johnson Surgical Vision, Inc. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.   For further information visit our website:  https://touchophthalmology.org

touchPANEL DISCUSSION for touchHAEMATOLOGY and touchONCOLOGY Listen to leading experts discuss guideline-directed strategies for mutational analysis and monitoring response when treating patients with chronic-phase chronic myeloid leukaemia with approved tyrosine kinase inhibitors. The experts Dr Jorge Cortes, Georgia Cancer Center, Augusta, GA, USA Dr Elias Jabbour, MD Anderson Cancer Center, Houston, TX, USA  Dr Vivian Oehler, Fred Hutch Cancer Center, Seattle, WA, USA This touchPODCAST is for HCPs in the USA only. This activity is funded by an independent medical education grant from Takeda Development Center Americas, Inc. Jointly provided by Partners for Advancing Clinical Education and touchIME. For further information, visit our websites:  www.touchHAEMATOLOGY.com www.touchONCOLOGY.com

touchEXPERT FOCUS for touchENDOCRINOLOGY Listen to a series of short interviews with paediatric endocrinologist Dr Ashley Shoemaker as she discusses the clinical manifestations and pathophysiology of Prader–Willi syndrome (PWS), with a focus on hyperphagia by exploring the spectrum across the lifespan of PWS and shares best practices for managing PWS-related hyperphagia within a multidisciplinary framework. The expert: Dr Ashley Shoemaker, Vanderbilt University Medical Center, Nashville, TN, USA This touchPODCAST is for HCPs in the USA only. This activity is funded by an independent medical education grant from Soleno Therapeutics. The activity is jointly provided by Partners for Advancing Clinical Education (Partners) and touchIME.   For further information, visit our website: https://touchendocrinologyime.org/hyperphagia-pws-recognition-management/

touchPANEL DISCUSSION for touchONCOLOGY and touchRESPIRATORY   Listen to leading experts discuss the role of antibody–drug conjugates (ADCs) in NSCLC with brain metastases, including the latest clinical trial evidence, practical approaches to patient selection and treatment sequencing alongside local CNS therapies, and the evolving pipeline of investigational ADCs. The expert(s) Dr Lyudmila Bazhenova, Moore’s Cancer Center, San Diego, CA, USA Dr Elvire Pons-Tostivint, Nantes Université, Centre Hospitalier Universitaire Nantes, France Dr Julia Rotow, Dana-Farber Cancer Institute, Boston, MA, USA This touchPODCAST is for HCPs only outside of the UK. This activity is funded by an independent medical education grant fromAstraZeneca. This activity is jointly provided by USF Health and touchIME.  touchIME is an EBAC® accredited provider. For further information visit our websites:  www.touchONCOLOGY.com www.touchRESPIRATORY.com

touchPANEL DISCUSSION for touchHAEMATOLOGY and touchONCOLOGY Listen to a panel of leading experts as they explore the latest advances in PNH pathophysiology, diagnostic approaches and therapeutic strategies, including data from ASH 2025, with practical insights for contemporary clinical practice. The experts: Prof. Bruno Fattizzo, Università degli Studi di Milano, Milan, Italy Dr Austin Kulasekararaj, King’s College Hospital NHS Foundation Trust, London, UK Dr Srikanth Nagalla, Miami Cancer Institute, Miami, FL, USA This touchPODCAST is for HCPs outside of the UK. This activity is funded by an independent medical education grant from Alexion Pharma GmbH. The activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: www.touchHAEMATOLOGY.com or www.touchONCOLOGY.com

touchCASES for touchNEUROLOGY, touchCARDIO, touchENDOCRINOLOGY and touchRESPIRATORY Listen to two experts as they discuss three cases illustrating the heterogeneous, multisystem nature of late-onset Pompe disease (LOPD). They examine key decision points from recognizing early clinical clues and confirming diagnosis to optimizing enzyme replacement therapy (ERT), monitoring progression and coordinating multidisciplinary, patient-centred care.  The experts: Prof. John Vissing, University of Copenhagen, Copenhagen, Denmark Prof. Pascal Laforêt, Versailles-Saint Quentin University, Versailles, France  This activity is for HCPs outside of the USA. This activity is supported by an independent educational grant from Amicus Therapeutics UK LTD. touchIME is an EBAC® accredited provider. For further information visit our websites:  touchNEUROLOGY -  https://touchneurologyime.org/diagnosis-monitoring-management-lopd/ touchCARDIO - https://touchcardioime.org/diagnosis-monitoring-management-lopd/ touchENDOCRINOLOGY - https://touchendocrinologyime.org/diagnosis-monitoring-management-lopd/ touchRESPIRATORY - https://touchrespiratoryime.org/diagnosis-monitoring-management-lopd/  

touchCONGRESS for touchHAEMATOLOGY and touchONCOLOGY Listen to multiple myeloma expert Dr Rakesh Popat review key data for BCMA-targeting agents in the treatment of relapsed/refractory multiple myeloma presented at the International Multiple Society (IMS) and American Society of Hematology (ASH) 2025 congresses. Dr Popat is then joined by fellow experts Dr Paula Rodríguez-Otero and Dr Roberto Mina to discuss the implications of these data for current and future clinical practice.   Overview Data reviews with Dr Popat Expert panel discussions with Dr Popat, Dr Rodríguez-Otero and Dr Mina on the themes below Clinical themes Approved BCMA-directed therapeutic approaches  Practical application of BCMA-directed therapies Future of treating RRMM: Emerging BCMA-directed therapies and combinations The internationally renowned multiple myeloma expert faculty Dr Rakesh Popat: London, UK Dr Paula Rodríguez-Otero: Pamplona, Spain Dr Roberto Mina: Atlanta, GA, USA This touchPODCAST is for HCPs outside of the USA.  This activity is funded by an independent medical education grant from GSK. This activity is provided by touchIME. touchIME is an EBAC® accredited provider. For further information, visit our website: www.touchHAEMATOLOGY.com and www.touchONCOLOGY.com

touchCLINICAL PERSPECTIVES for touchONCOLOGY and touchRESPIRATORY Module 1: Beyond EGFR: Addressing actionable drug resistance mechanisms In this module, Professors Jänne and Girard explore the challenges of resistance to EGFR-targeted therapies in non-small cell lung cancer. They discuss how mechanisms such as MET and HER2 amplification drive resistance to first-line osimertinib, review emerging targeted strategies to overcome these barriers, and highlight the importance of biomarker testing and managing treatment side effects when shaping second-line options for patients. Course director Prof. Pasi Jänne, Dana-Farber Cancer Institute, Boston, MA, USA The clinical expert Prof. Nicholas Girard, Institut Curie, Paris, France   Module 2: Bridging resistance gaps post–EGFR-TKI: Expanding NSCLC treatment beyond actionable targets In this module, Professor Pasi Jänne and Dr. Helena Yu discuss the evolving management of EGFR-mutant NSCLC after EGFR-TKI progression. They address challenges of unexplained resistance, review combination and ADC treatment approaches, and highlight key factors such as patient selection, safety and emerging biomarkers Course director Prof. Pasi Jänne, Dana-Farber Cancer Institute, Boston, MA, USA The clinical expert Dr Helena Yu, Memorial Sloan Kettering Cancer Center, New York, NY, USA   Module 3: Targeting resistance in EGFR-mutant NSCLC: The role of biomarkers In this module, Professor Pasi Jänne and Professor Paul Hofman explore how precision medicine and molecular resistance mechanisms are shaping testing strategies. They discuss the role of biomarkers, evolving guideline recommendations and how clinicians can adapt testing approaches to align with new targeted therapies. Course director Prof. Pasi Jänne, Dana-Farber Cancer Institute, Boston, MA, USA The clinical expert Prof. Paul Hofman, University Côte d’Azur, Nice, France.     This touchPODCAST is for HCPs only. This activity is funded by an educational grant from AstraZeneca Ltd.  This medical education is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website:   https://touchoncologyime.org/egfr-tki-resistance-strategies-nsclc/ https://touchrespiratoryime.org/egfr-tki-resistance-strategies-nsclc/  

touchEXPERT FOCUS for touchONCOLOGY Listen to insights from Dr Kathleen Moore on the pathophysiology and molecular features of low-grade serous ovarian cancer (LGSOC) and how it differs from other ovarian cancers. She also discusses evidence-based treatment options and sequencing, as well as practical considerations relating to administration and side-effect management. The expert: Dr Kathleen Moore, OH Health Stephenson Cancer Center, Oklahoma City, OK, USA This touchPODCAST is for HCPs in the USA only. This activity is funded by an independent medical education grant from Verastem, Inc. The activity is jointly provided by Partners for Advancing Clinical Education and touchIME. For further information visit our website: www.touchONCOLOGY.com

touchIN CONVERSATION for touchHAEMATOLOGY The presence of anaemia and/or thrombocytopenia complicates the management of patients with myelofibrosis (MF). Listen to expert haematologists consider the burden of cytopenias in patients with MF and discuss strategies to reduce transfusion dependence, improve splenomegaly and personalize treatment with JAK inhibitors. The experts Prof. Claire Harrison, Guy’s and St Thomas’ NHS Foundation Trust, London, UK Dr Laura Fox, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain This touchPODCAST is for HCPs outside of the USA. This activity is supported by an independent medical education grant from GSK. This activity is provided by touchIME in collaboration with our Education Partner Haematology Nurses & Healthcare Professionals Group (HNHCP). touchIME is an EBAC® accredited provider. For further information visit our website: www.touchHAEMATOLOGY.com

touchEXPERT FOCUS for touchHAEMATOLOGY and touchONCOLOGY Listen to a series of short interviews with three leading experts who provide their insights into early-line management of chronic myeloid leukaemia and the impact on quality of life. The experts: Dr Delphine Rea, Hôpital Saint-Louis, Paris, France  Prof. Andreas Hochhaus, Jena University Hospital, Jena, Germany Prof. Etab Atallah, Medical College of Wisconsin, Milwaukee, WI, USA This activity is for healthcare professionals outside of the USA and UK. This independent medical education is supported by Novartis and is provided by touchIME. For further information visit our website: www.touchHAEMATOLOGY.com or www.touchONCOLOGY.com

touchTALKS for touchONCOLOGY Listen to Dr Christine Bestvina, as she evaluates the latest data on KRAS mutations in NSCLC and explores how emerging evidence for targeted therapies could influence clinical decision-making. The expert Dr Christine Bestvina, University of Chicago, Chicago, IL, USA This touchPODCAST is for HCPs outside of the UK. This activity is funded by an independent medical education grant from Revolution Medicines. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.  For further information visit our website: www.touchONCOLOGY.com

touchEXPERT FOCUS for touchONCOLOGY Listen to a series of short interviews with four leading experts as they discuss the role of HER2 as a targetable biomarker in BTC and GEA. They examine the present treatment landscape for HER2-positive BTC and GEA and evaluate clinical implications of recent approvals and advances in current and emerging HER2-targeting therapies for HER2-positive BTC and GEA.  The experts Prof. Thomas Seufferlein, Ulm University, Ulm, Germany Dr Elizabeth Smyth, Oxford University Hospitals NHS Foundation Trust, Oxford, UK Prof. Florian Lordick, University of Leipzig, Leipzig, Germany Prof. Eric Van Cutsem, University of Leuven, Leuven, Belgium This touchPODCAST is for HCPs outside of the UK This activity is supported by an independent educational grant from Jazz Pharmaceuticals.  Jointly provided by Partners for Advancing Clinical Education and touchIME.  touchIME is an EBAC® accredited provider.  For further information visit our website:  www.touchONCOLOGY.com

touchPANEL DISCUSSION for touchONCOLOGY and touchENDOCRINOLOGY Listen to a panel of leading experts discuss the optimal management of gastroenteropancreatic neuroendocrine tumours (GEP-NETs), with a focus on peptide receptor radionuclide therapy (PRRT). The faculty provide their insights on the current state of the art, the evolving role of PRRT in GEP-NET treatment, and recent data with existing and emerging PRRT agents. The faculty will also consider future developments in this field, including personalized approaches to PRRT, and how they might impact clinical care. The experts: Prof. Thorvardur Halfdanarson, Mayo Clinic Rochester, MN, USA Prof. Rocio Garcia-Carbonero, Hospital Universitario 12 de Octubre, Madrid, Spain Prof. Nicola Fazio, European Institute of Oncology, Milan, Italy This touchPODCAST is for HCPs outside of the UK. This activity is funded by an independent medical education grant from ITM Isotope Technologies Munich SE. The activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our websites: www.touchONCOLOGY.com and www.touchENDOCRINOLOGY.com

touchCLINICAL PERSPECTIVES for touchONCOLOGY and touchRESPIRATORY Module 1: Beyond EGFR: Addressing actionable drug resistance mechanisms In this module, Professors Jänne and Girard explore the challenges of resistance to EGFR-targeted therapies in non-small cell lung cancer. They discuss how mechanisms such as MET and HER2 amplification drive resistance to first-line osimertinib, review emerging targeted strategies to overcome these barriers, and highlight the importance of biomarker testing and managing treatment side effects when shaping second-line options for patients. Course director Prof. Pasi Jänne, Dana-Farber Cancer Institute, Boston, MA, USA The clinical expert Prof. Nicholas Girard, Institut Curie, Paris, France Module 2: Bridging resistance gaps post–EGFR-TKI: Expanding NSCLC treatment beyond actionable targets In this module, Professor Pasi Jänne and Dr Helena Yu discuss the evolving management of EGFR-mutant NSCLC after EGFR-TKI progression. They address challenges of unexplained resistance, review combination and ADC treatment approaches, and highlight key factors such as patient selection, safety and emerging biomarkers Course director Prof. Pasi Jänne, Dana-Farber Cancer Institute, Boston, MA, USA The clinical expert Dr Helena Yu, Memorial Sloan Kettering Cancer Center, New York, NY, USA This touchPODCAST is for HCPs only. This activity is funded by an educational grant from AstraZeneca Ltd.  This medical education is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website:   https://touchoncologyime.org/egfr-tki-resistance-strategies-nsclc/ https://touchrespiratoryime.org/egfr-tki-resistance-strategies-nsclc/  

touchEXPERT FOCUS for touchOPHTHALMOLOGY Listen to a series of interviews with two medical retina specialists and a biomarker expert who will provide their insights into the pathophysiology of diabetic macular oedema (DMO), including the inflammatory mechanisms of disease and how they may impact treatment. The faculty will also consider the clinical utility of optical coherence tomography (OCT) imaging biomarkers and emerging evidence on the evolving role of corticosteroids in the management of DMO. The experts: Prof. Stela Vujosevic, Medical Retina Unit, IRCCS MultiMedica and University of Milan, Milan, Italy Prof. Francesco Bandello, University Vita-Salute, San Raffaele Scientific Institute, Milan, Italy Prof. Laurent Kodjikian, University of Lyon and Croix-Rousse University Hospital, Lyon, France This touchPODCAST is for HCPs outside of the UK and USA. This activity is funded by an independent medical education grant from Alimera Sciences Europe Ltd. The activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: www.touchOPHTHALMOLOGY.com

touchPANEL DISCUSSION for touchNEUROLOGY Listen to a panel of experts in epilepsy as they discuss how to promptly and accurately diagnose and manage Lennox–Gastaut syndrome (LGS). Moderated by a leading European expert, this episode brings together faculty from the Gulf region and Japan, as they explore diagnostic approaches in their regions, before sharing their unique regional perspectives and real-world experience in caring for patients with LGS.   The experts Prof. Nicola Specchio: Bambino Gesù Children’s Hospital, IRCCS, Rome, Italy Dr Raidah Al-Baradie: King Fahad Specialist Hospital, Dammam, Saudi Arabia Dr Taoufik Alsaadi: American Center for Neurology, Abu Dhabi, Dubai, UAE Prof. Eiji Nakagawa: National Center of Neurology and Psychiatry, Tokyo, Japan Prof. Hideo Yamanouchi: Saitama Medical University, Saitama, Japan Chapters The disease state of LGS (00:00–18:47) Managing patients with LGS in the Gulf (18:48–37:00) Managing patients with LGS in Japan (37:01–56:25) This touchPODCAST is for HCPs outside of the UK only.  This activity is supported by an independent medical educational grant from Jazz Pharmaceuticals.  Jointly provided by Partners for Advancing Clinical Education and touchIME. touchIME is an EBAC® accredited provider. For further information visit: touchneurologyime.org/diagnosis-treatment-lennox-gastaut-syndrome/

touchEXPERT FOCUS for touchCARDIO Listen to short interviews with two expert cardiologists discussing the role of current and emerging therapeutic classes that aim to address the unmet needs of patients with hypertrophic cardiomyopathy. The faculty will review current therapeutic approaches for managing obstructive versus nonobstructive hypertrophic cardiomyopathy to highlight existing gaps in patient care. They will then discuss the latest data for emerging therapeutic classes and consider how they may address patients’ unmet needs in the future.    The experts Dr Martin Maron, Lahey Hospital & Medical Center, Burlington, MA, USA Dr Michelle Michels, Erasmus MC, Rotterdam, The Netherlands This touchPODCAST is for healthcare professionals outside of the UK. This activity is supported by an independent medical educational grant from Cytokinetics, Inc. Jointly provided by Partners for Advancing Clinical Education and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website:  https://touchcardio.com/

Module 1: Beyond EGFR: Addressing actionable drug resistance mechanisms touchCLINICAL PERSPECTIVES for touchONCOLOGY and touchRESPIRATORY In this module, Professors Jänne and Girard explore the challenges of resistance to EGFR-targeted therapies in non-small cell lung cancer. They discuss how mechanisms such as MET and HER2 amplification drive resistance to first-line osimertinib, review emerging targeted strategies to overcome these barriers, and highlight the importance of biomarker testing and managing treatment side effects when shaping second-line options for patients. Course director Prof. Pasi Jänne, Dana-Farber Cancer Institute, Boston, MA, USA The clinical expert Prof. Nicholas Girard, Institut Curie, Paris, France This touchPODCAST is for HCPs only. This activity is funded by an educational grant from AstraZeneca Ltd.  This medical education is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website:   touchONCOLOGY: https://touchoncologyime.org/egfr-tki-resistance-strategies-nsclc/ touchRESPIRATORY: https://touchrespiratoryime.org/egfr-tki-resistance-strategies-nsclc/  

touchEXPERT FOCUS for touchONCOLOGY Listen to insights from Prof. Jean-Pascal Machiels on optimizing the use of immunotherapy in patients with recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) and the potential future role of immunotherapy in resectable locally advanced HNSCC. The expert: Prof. Jean-Pascal Machiels, Cliniques universitaires Saint-Luc, Brussels, Belgium This touchPODCAST is for HCPs outside of the UK. This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC. The activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: www.touchONCOLOGY.com

touchIN CONVERSATION for touchCARDIOLOGY and touchENDOCRINOLOGY Listen to two experts as they discuss the diagnosis, treatment and how to support patients with FCS. They cover how to recognize key clinical signs and symptoms, strategies to help manage symptoms, reduce triglyceride levels and prevent complications. They  also share key insights from their experience with novel targeted therapies for FCS. The expert(s) Professor Antonio Gallo, Sorbonne University Hospital Pitié-Salpêtrière, Paris, France Dr Vikesh Singh, Johns Hopkins University School of Medicine, Baltimore, MD, USA This touchPODCAST is for HCPs in the USA and Europe only. This activity is funded by an independent medical education grant from Arrowhead Pharmaceuticals, Inc. This activity is jointly provided by USF Health and touchIME.  touchIME is an EBAC® accredited provider. For further information visit our websites: https://touchcardioime.org/fcs-unmasked/ and https://touchendocrinologyime.org/fcs-unmasked/

touchEXPERT FOCUS for touchHAEMATOLOGY Prof. Lucia de Franceschi, a leading expert in sickle cell disease, examines the clinical manifestations and burden of the condition, reviews current and emerging treatments and offers guidance on comprehensive lifespan care that addresses complications, quality of life, and disparities, while highlighting the essential role of multidisciplinary support. The experts Prof. Lucia de Franceschi, University of Verona, Italy This touchPODCAST is for HCPs outside of the UK. This activity is funded by an independent medical education grant from Agios Pharmaceuticals, Inc. The activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: www.touchHAEMATOLOGY.com

touchEXPERT FOCUS for touchENDOCRINOLOGY, touchCARDIO and touchNEUROLOGY Listen to a series of short expert interviews on timely diagnosis and individualized care for Fabry disease, using genetic and clinical insights. Our faculty discuss strategies to reduce diagnostic delays, identify clinically relevant genetic variants and tailor treatment based on each patient's genotype–phenotype correlations. The experts Dr Raphael Schiffmann, Texas Christian University, Fort Worth, TX, USA Ms Dawn Laney, Emory Genetic Clinical Trials Center, Atlanta, GA, USA Dr Ozlem Goker-Alpan, Lysosomal Disorders Research and Treatment Center (LDRTC), Fairfax, VA, USA This touchPODCAST is for HCPs outside of the UK. This activity is funded by an independent medical education grant from Amicus Therapeutics Inc. This activity is jointly provided by USF Health and touchIME. For further information visit our websites:  www.touchENDOCRINOLOGY.com www.touchCARDIO.com and www.touchNEUROLOGY.com

touchCASES for touchONCOLOGY Listen to three experts as they discuss how patient and disease characteristics may inform treatment selection in recurrent/metastatic nasopharyngeal carcinoma (R/M NPC). They will discuss the cases of three patients which will cover first-line and second-line treatments as well as key considerations for their treatment plans in their patients' cases. The experts: Dr Nabil Saba, Winship Cancer Institute, Emory University, Atlanta, GA, USA Dr Victoria Villaflor, Chao Family Comprehensive Cancer Center, UCI Health, Orange, CA, USA This activity is for HCPs in the USA only This activity is funded by an independent medical education grant from Coherus Biosciences. This activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchoncologyime.org/treatment-selection-in-r-m-npc/  

touchEXPERT FOCUS for touchHAEMATOLOGY and touchONCOLOGY Listen to a series of short expert interviews on the role of B-cell maturation antigen (BCMA)-directed therapies in relapsed/refractory multiple myeloma (RRMM). The faculty discuss patient selection, treatment tailoring and strategies to manage side effects, providing practical guidance for integrating BCMA-targeting approaches into care. The experts Prof. Jesús San Miguel, Cancer Center Clínica Universidad de Navarra (CCUN), Pamplona, Spain Prof. Pieter Sonneveld, Erasmus University Medical Center, Rotterdam, The Netherlands Dr Francesca Gay, University of Torino, Italy This touchPODCAST is for HCPs outside of the USA. This activity is funded by an independent medical education grant from GSK. This activity is provided by touchIME. touchIME is an EBAC® accredited provider. For further information visit our websites: www.touchHAEMATOLOGY.com and www.touchONCOLOGY.com 

touchEXPERT FOCUS for touchOPHTHALMOLOGY Listen to a series of short interviews with leading experts on phacoemulsification in cataract surgery. The faculty discuss optimizing fluidics and ultrasound energy, ophthalmic viscosurgical device selection, and integrating technological advances in phacoemulsification into clinical practice. The experts: Dr Ike K Ahmed, Prism Eye Institute, Toronto, ON, Canada; John A. Moran Eye Center, University of Utah, Salt Lake City, UT, USA Dr David F Chang, University of California, San Francisco, CA, USA; Altos Eye Physicians, Los Altos, CA, USA Dr Jennifer Loh, Loh Ophthalmology Associates, Miami, FL, USA This touchPODCAST is for HCPs in the USA, Latin America and Canada only. This activity is funded by an independent medical education grant from Alcon Vision, LLC and Johnson & Johnson Surgical Vision, Inc. The activity is jointly provided by USF Health and touchIME. For further information visit our website: https://touchophthalmologyime.org/phacoemulsification-cataract-surgery/    

touchEXPERT FOCUS for touchOPHTHALMOLOGY Listen to a series of interviews with Prof. Elias Traboulsi on the clinical presentation, diagnosis and management of patients with Stargardt disease. Prof. Traboulsi shares key clinical characteristics and retinal imaging results indicative of Stargardt disease, discusses the right tools to use to accurately and promptly diagnose the condition, and reviews supportive care strategies to maximize patients’ functional vision and improve their wellbeing.  The expert: Prof. Elias Traboulsi, Cleveland Clinic, Cleveland, OH, USA This touchPODCAST is for HCPs in the USA only. This activity is funded by an independent medical education grant from Alkeus Pharmaceuticals, Inc. The activity is jointly provided by USF Health and touchIME. For further information visit our website: www.touchOPHTHALMOLOGY.com

touchTALKS for touchENDOCRINOLOGY  Listen to Prof. Jennifer Sherr, as she discusses key updates on the prevention and management of DKA. The discussion covers the clinical features and aetiology of DKA, its impact on people living with diabetes, the underlying metabolic pathways, risk factors, common triggers, and the pillars of management. Prof. Sherr also explores strategies for prevention and early intervention plus the advantages, drawbacks and recent developments in ketone monitoring. The experts Prof. Jennifer Sherr, Yale School of Medicine, New Haven, CT, US This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Abbott Diabetes Care Inc. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider.  For further information visit our website:  www.touchENDOCRINOLOGY.com

touchCASES for touchRESPIRATORY and touchCARDIO This touchCASES activity presents expert-led discussions exploring three clinical cases of pulmonary arterial hypertension (PAH). Through these detailed cases, the expert faculty examine a range of clinical presentations and highlight critical decision points across the patient journey, from initial diagnosis and risk stratification to treatment initiation and escalation. The experts: Dr Athénaïs Boucly, University of Paris-Saclay, Le Kremlin-Bicêtre, Paris, France Prof. Pilar Escribano Subìas, Complutense University of Madrid, Spain This touchPODCAST is for HCPs outside the UK This activity is provided by an independent medical education grant from Merck Sharp & Dohme LLC. The activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider For further information, visit our websites: www.touchRESPIRATORY.com and www.touchCARDIO.com

touchEXPERT FOCUS for touchCARDIO and touchENDOCRINOLOGY Listen to two experts discuss how continuous glucose monitoring (CGM) can help identify and manage cardiovascular risk in people with or without diabetes. They explore the role of glycaemic variability, the limitations of conventional glucose metrics, and the added value of CGM, including recent advances and patient education to support effective use. The experts: Dr Eden Miller, Diabetes and Obesity Care, Bend, OR, USA Dr Ian J Neeland, Case Western Reserve University, and Harrington Heart and Vascular Institute, University Hospitals Cleveland, OH, USA This activity is for HCPs outside of the UK. This activity is funded by an independent medical education grant from Abbott Diabetes Care Inc. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: www.touchCARDIO.com and www.touchENDOCRINOLOGY.com

touchEXPERT FOCUS for touchONCOLOGY Listen to a series of short interviews with three leading experts as they discuss the use of HER2 as a targetable biomarker in gastrointestinal oncology. The faculty cover the clinical significance of HER2 alterations, best practices for biomarker testing, key clinical trial data on efficacy and safety, and the role of HER2-targeted therapies in both common and rare GI cancers. They also address retesting at progression, management of adverse events, and emerging treatment approaches. The experts Dr Yelena Janjigian, Memorial Sloan Kettering Cancer Center, New York, NY, USA Prof. Eric Van Cutsem, University of Leuven, Leuven, Belgium Prof. Florian Lordick, University of Leipzig, Leipzig, Germany This touchPODCAST is for HCPs outside of the UK This activity is funded by an independent medical education grant from AstraZeneca.  This activity is jointly provided by USF Health and touchIME.  touchIME is an EBAC® accredited provider.  For further information visit our website:  www.touchONCOLOGY.com 

touchPANEL DISCUSSION for touchONCOLOGY Listen to three leading international experts in gynaecological oncology as they discuss how immunotherapy is transforming the treatment of advanced endometrial carcinoma. The faculty explore how the latest data are shaping first-line treatment decisions, how to personalize therapy using biomarkers and molecular classification, and how to manage immune-related adverse events through practical monitoring strategies. The experts Prof. Isabelle Ray-Coquard, Centre Léon Bérard, Lyon, France Prof. Nicoletta Colombo, University of Milan-Bicocca, Milan, Italy Dr Brian Slomovitz, Mount Sinai Medical Center, Miami, FL, USA This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchoncologyime.org/panel-icis-in-ec/ 

touchEXPERT FOCUS for touchNEUROLOGY and touchCARDIO Listen to Dr Chafic Karam share expert insights on diagnosing and managing ATTRv amyloidosis. In this short interview, he covers red-flag symptoms, diagnostic challenges and key strategies for differentiating ATTRv. He also discusses current treatment options, including TTR stabilisers and gene silencers, as well as emerging therapies aimed at improving patient outcomes. The expert: Dr Chafic Karam, University of Pennsylvania, Philadelphia, PA, USA This touchPODCAST is for HCPs in the USA only. This activity is funded by an independent medical education grant from AstraZeneca. This activity is jointly provided by USF Health and touchIME. For further information visit our websites:  https://touchneurology.com/ and https://touchcardio.com/

touchCONGRESS for touchHAEMATOLOGY and touchONCOLOGY Listen to multiple myeloma expert Prof. Philippe Moreau review key data for BCMA-targeting agents in the treatment of relapsed/refractory multiple myeloma presented at the international Controversies in Multiple Myeloma (COMy), American Society of Clinical Oncology (ASCO) and European Hematology Association (EHA) 2025 congresses. Prof. Moreau is then joined by fellow experts Dr Paola Neri and Prof. Hermann Einsele to discuss how these data may apply in clinical practice. Overview Data reviews with Prof. Moreau Expert panel discussions with Prof. Moreau, Dr Neri and Prof. Einsele on the themes below Clinical themes Approved BCMA-directed therapeutic approaches  Practical application of BCMA-directed therapies Future of treating RRMM: Emerging BCMA-directed therapies and combinations The internationally renowned multiple myeloma expert faculty Prof. Philippe Moreau: Nantes, France Prof. Hermann Einsele: Würzburg, Germany Dr Paola Neri: Calgary, AB, Canada This touchPODCAST is for HCPs outside of the USA.  This activity is funded by an independent medical education grant from GSK. This activity is provided by touchIME. touchIME is an EBAC® accredited provider. For further information, visit our website: www.touchHAEMATOLOGY.com and www.touchONCOLOGY.com

touchEXPERT FOCUS for touchDERMATOLOGY Listen to Prof. Ilona Frieden share expert insights on the clinical management of infantile haemangiomas, with a focus on timely referral and effective risk stratification. She also explores current and emerging treatment options and practical strategies to support families throughout a patient’s care journey.  The expert: Prof. Ilona Frieden, University of California, San Francisco, CA, USA This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Pierre Fabre Pharmaceuticals, Inc. This activity is jointly provided by USF Health and touchIME in collaboration with our education partner, Pediatric Dermatology Research Alliance (PeDRA). For further information visit our website: https://touchdermaime.org/

touchIN CONVERSATION for touchONCOLOGY Listen to two oncologists discuss the incorporation of antibody–drug conjugates (ADCs) into the treatment of metastatic breast cancer, tackling questions submitted by the oncology community. They discuss how treatment can be guided by biomarkers, give practical insights into creating a personalized care plan for patients, and share strategies for managing ADC-associated toxicities. The experts Prof. Giuseppe Curigliano, European Institute of Oncology and University of Milan, Italy Dr Alison Conlin, Providence Cancer Institute, Portland, OR, USA This touchPODCAST is for HCPs outside of the UK.  This activity is funded by an independent medical education grant from Gilead Sciences, Inc. The activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information, visit our website: https://touchoncologyime.org/adcs-in-the-treatment-of-mbc/  

touchEXPERT FOCUS for touchONCOLOGY Listen to a series of short interviews with three leading experts discussing the application of immunotherapy in triple-negative breast cancer (TNBC). The experts explore the latest data and guideline recommendations for immunotherapy in early-stage and metastatic TNBC, and how to maximize treatment benefits.  The experts: Prof. Sherko Kümmel – Kliniken Essen-Mitte, Essen, Germany Prof. Rebecca Dent – National Cancer Center Singapore, Singapore Prof. Peter Schmid – Barts Cancer Institute, London, UK This touchPODCAST is for healthcare professionals outside of the UK. This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC.  This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information visit our website: https://touchoncologyime.org/management-of-tnbc-with-immunotherapy/  

touchEXPERT FOCUS for touchRESPIRATORY Listen to Prof. Jonathan Spicer share expert insights on immunotherapy in early-stage non-small cell lung cancer (NSCLC). He explores current treatment strategies, highlights the role of neoadjuvant, perioperative and adjuvant approaches, and considers practical aspects of clinical implementation. The expert Prof. Jonathan Spicer, McGill University, Montreal, Canada This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC. The activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information, visit our website: https://touchrespiratoryime.org/touchexpert-focus-immunotherapy-early-stage-nsclc/  

touchEXPERT FOCUS for touchONCOLOGY Listen to Prof. Jonathan Spicer share expert insights on immunotherapy in early-stage non-small cell lung cancer (NSCLC). He explores current treatment strategies, highlights the role of neoadjuvant, perioperative and adjuvant approaches, and considers practical aspects of clinical implementation. The expert Prof. Jonathan Spicer, McGill University, Montreal, Canada This touchPODCAST is for HCPs outside of the UK only. This activity is funded by an independent medical education grant from Merck Sharp & Dohme LLC. The activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information, visit our website: https://touchoncologyime.org/touchexpert-focus-immunotherapy-early-stage-nsclc/  

NEW touchCASES for touchINFECTIOUS DISEASES Listen to  Prof. José Arribas, a leading HIV expert, and Ms Harriet Langanke, a journalist and HIV activist, discuss personalized care strategies for people living with HIV, focusing on three key concerns: weight gain, pill fatigue and treatment initiation. The experts: Prof. José Arribas, University Hospital La Paz, Madrid, Spain, Ms Harriet Langanke, GSSG, Cologne, Germany This touchPODCAST is for HCPs outside of the UK This activity is funded by an independent medical education grant from Viiv Healthcare. This activity is jointly provided by USF Health and touchIME. touchIME is an EBAC® accredited provider. For further information, visit our website: https://touchinfectiousdiseases.com

touchFOCUS for touchRESPIRATORY In this concise interview, Dr Christine Bestvina discusses the key clinical questions surrounding currently approved RET inhibitors in NSCLC. The expert: Dr Christine Bestvina - University of Chicago, Chicago, IL, USA This touchPODCAST is for HCPs outside the UK.  This activity is funded by an independent medical education grant from Rigel Pharmaceuticals Inc. This activity is jointly provided by USF Health and touchIME. For further information visit our website: touchrespiratory.com

touchFOCUS for touchONCOLOGY In this concise interview, Dr Christine Bestvina discusses the key clinical questions surrounding currently approved RET inhibitors in NSCLC. The expert: Dr Christine Bestvina - University of Chicago, Chicago, IL, USA This touchPODCAST is for HCPs outside the UK.  This activity is funded by an independent medical education grant from Rigel Pharmaceuticals Inc. This activity is jointly provided by USF Health and touchIME. For further information visit our website: touchoncology.com

touchEXPERT FOCUS touchOPHTHALMOLOGY Listen to Dr Laura Periman share expert insights on dry eye disease. In this episode, she explores the pathophysiological mechanisms behind the condition, highlights key diagnostic tools, reviews current treatment options—including exciting advances in neuromodulation therapies—and discusses emerging targeted approaches shaping clinical management today.   The expert Dr Laura Periman, Periman Eye Institute, Seattle, WA, USA This touchPODCAST is for HCPs outside of the UK.  This activity is funded by an independent medical education grant from Alcon Vision, LLC. The activity is jointly provided by USF Health and touchIME.  For further information, visit our website: https://touchophthalmologyime.org/advances-in-dry-eye-disease/